← Eichor
Study identifier: NCT07001449 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Communication-Focused Pain Neuroscience Education in Chronic Musculoskeletal Pain

Condition: Chronic Musculoskeletal Pain  ·  Sponsor: University of Thessaly

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This randomized controlled trial aims to evaluate the effectiveness of the "Algo(S)Therapy" Pain Neuroscience Education (PNE) program in patients with chronic musculoskeletal pain. The study will assess whether the integration of communication skills training for physiotherapists enhances the outcomes of PNE. Participants will be randomly assigned to one of three groups: (1) PNE with communication-focused delivery, (2) PNE without communication emphasis, or (3) standard- usual physiotherapy care. The primary objective is to determine whether PNE combined with enhanced communication skills leads to greater improvements in pain, function, and psychosocial outcomes compared to the other interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Konstantina Savvoulidou  ·  +30 22310 6017  ·  ksavvoulidou@uth.gr

Always discuss trial participation with your own doctor first.

Locations (1)

Physiotherapy Department, University of Thessaly, GreeceLamia, Central Greece, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07001449